"SPECIAL CHARTIST VIEW REPORT BY EPIC RESEARCH-8 JANUARY 2013"
8TH January 2013 DAILY CHARTIST VIEW HIGHLIGHTS A Highlights Nifty showed bearish trend on Monday. Nifty Future ended 31.95 points down at 6016.05 Bharti Airtel sell call we recommended executed today and is currently trading at cost Tata Chemicals sell call remained unexecuted Investors’ are advised to hold position in Bharti Airtel sell call and take position in the fresh call provided below. Sell Bharti Airtel futures below 328.45 for targets 327/325 Sell Auro Pharma futures below 200 for targets 198/195 Past Performance: Allahabad bank buy call hit both targets. Auro Pharma buy call hit 1st target. JSW Steel buy call hit both targets. Allahabad bank sell call hit both targets. Voltas hit both targets Adani Enterprise hit target. Lupin almost hit 2nd target. Havells sell call hit both targets. BHARTI AIRTEL FUTURES – RISING WEDGE SELL BELOW 328.45 FOR TARGETS 327/325 SL 330.50 BUY ABOVE 250 FOR TARGETS OF 265/285 SL 235 Bharti Airtel sell we recommended executed today. It made a low of 327.65 near to our 1st target 327 Currently trading at cost at 328.50 Investors’ are advised to hold the position with recommended SL Targets are 327/325 and SL is recommended at 330.50 Bharti Airtel is making Rising wedge on hourly chart AURO PHARMA FUTURES– DOUBLE TOP SELL BELOW 200 FOR TARGETS 198/195 SL 202 Sell Auro Pharma future below 200 Auro Pharma is making Double top on hourly chart Currently trading at 202.70 Investors’ are advised to sell below 200 for targets 198/195 SL is recommended at 367.50 Auro Pharma is having strong support at 200.50 and the call may take time in execution. Disclaimer The information and view in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE. The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer. All Rights Reserved. Investment in equity & bullion market has its own risks. We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any other information provided by us to/with anyone which is related directly or indirectly with them. If found so, then Serious Legal Actions can be taken.